ARCH Advanced Revascularization Symposium
Avatar

Paclitaxel DCB: Back to the Dark Ages for PAD?

By ARCH Advanced Revascularization Symposium FEATURING George Chrysant
By ARCH Advanced Revascularization Symposium FEATURING George Chrysant
29 views
May 28, 2019
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
42:25
Piedmont Heart Institute

Peripheral Arterial Disease: How To Prevent? When To Diagnose? How T…

Feat. A. Klein
13:46
NY Endovascular Summit

Medical Management of Peripheral Arterial Disease

Feat. H. Kamran
06:13
Cordis

Radial Peripheral Case Review (3/4): Left SFA Revascularization via …

Feat. G. Adams
13:10
TCT 2023 Insights

TCT 2023 Insights: Best CLTI Case of The Year

Feat. H. Lichaa
44
Boston Scientific

COMPARE Trial Perspectives

Feat. D. Scheinert
09:20
Shockwave IVL

Intravascular Lithotripsy and Drug-Coated Balloon Angioplasty for Se…

Feat. K. Stavroulakis
09:46
NY Endovascular Summit

The Sirolimus Option

Feat. A. Virmani Finn
66:39
Philips

Live Case with Dr. George Adams and Philips Laser Atherectomy

Feat. G. Adams
17:49
CHEST 2022 Coverage

Perioperative Management of Antithrombotic Therapy

Feat. J. Douketis
14:38
American Heart & Vascular Institute

Why Every Physician Must Diagnose Peripheral Artery Disease? How Can…

Feat. S. Khan
08:30
Philips

Stellarex DCB Design and Performance for Proven Clinical Success

01:49
Philips

DCB coating designs and particulate levels

17:24
ARCH Advanced Revascularization Symposium

Interventional Tool Kit (Guide Wires / Balloons, etc.)

Feat. G. Chrysant
01:19
Philips

Explore Paclitaxel forms: amorphous vs crystalline

01:09
Philips

DCB coating reactions vary when hydrated

40
Boston Scientific

Ranger DCB Platform and Compatibility

Feat. N. Shammas
10:56
NY Endovascular Summit

Medical Management of PAD: Current Data and Recommendations

Feat. J. Olin
09:19
The North American Thrombosis Forum (NATF)

Clot Chronicles: Peripheral Artery Disease — What Clinicians Should …

Feat. M. Mcdermott
09:56
CVC 2018

DES for Infra-Popliteal Disease: What’s the Latest Data?

Feat. P. Soukas
10:25
NY Endovascular Summit

Drug-Eluting Technology for Below-the-Knee Intervention

Feat. M. Bunte